Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, breast disorder, breast neoplasm, carcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, kidney cancer, kidney disorder, neoplasm, rectal disorder, renal cell carcinoma, skin disorder, transitional cell carcinoma, triple-negative breast carcinoma, urinary system disorderRecruitingPhase 1 / Phase 22026-08-11NCT05706129

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Lumara Bio Oncologics GmbH3

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AP-HM - Hopital de la TimoneMarseilleFrance2
Centre Georges François LeclercDijonFrance42
Centre Jean PerrinClermont-FerrandFrance58
Centre Léon BérardLyonFrance77
CHRU de Nancy - Hopitaux de BraboisVandœuvre-lès-NancyFrance2
CHU de Grenoble-Alpes, Boulevard de la ChantourneGrenobleFrance1
Chu de NantesNantesFrance72
IUCT - OncopoleToulouseFrance2
Peter MacCallum Cancer CentreMelbourneAustralia2
UNSW Sydney, St Vincent's Hospital SydneySydneyAustralia1